Recombinant soluble low density lipoprotein receptor fragment inhibits minor group rhinovirus infection in vitro

FASEB J. 1998 Jun;12(9):695-703. doi: 10.1096/fasebj.12.9.695.

Abstract

A fragment of the low density lipoprotein receptor encompassing the seven ligand binding repeats was expressed in Sf9 insect cells as a fusion protein with a carboxyl-terminally linked hexa-his tag by using a baculovirus vector. Up to 10 mg/l of the fusion protein was secreted into the medium. The material was soluble in the absence of detergent and active in binding beta very low density lipoprotein and a member of the minor group of human rhinoviruses (HRV2) in ligand blots from sodium dodecyl sulfate-polyacrylamide gels run under nonreducing conditions. The receptor fragment specifically inhibits viral infection of HeLa cells by minor group HRVs in a concentration-dependent manner. Viral infectivity is neutralized by aggregation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Baculoviridae / genetics
  • Cloning, Molecular
  • Humans
  • Ligands
  • Peptide Fragments / genetics
  • Peptide Fragments / pharmacology*
  • Receptors, LDL* / genetics
  • Recombinant Fusion Proteins / pharmacology
  • Rhinovirus / drug effects*
  • Sequence Analysis
  • Solubility
  • Spodoptera / cytology

Substances

  • Ligands
  • Peptide Fragments
  • Receptors, LDL
  • Recombinant Fusion Proteins